Patents by Inventor Pavel Lazarev

Pavel Lazarev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240016462
    Abstract: In some embodiments, an X-ray system comprises a work-station and a mammography apparatus. The mammography apparatus can comprise: a breast positioning area; an absorption contrast imaging apparatus; and a diffractometer for analyzing structure of tissue within a breast. The absorption contrast imaging apparatus and the diffractometer can be configured to move in order to interchangeably align with the breast positioning area. The work-station can be configured to control the mammography apparatus, and to process data received from the mammography apparatus.
    Type: Application
    Filed: July 13, 2023
    Publication date: January 18, 2024
    Applicant: EosDx Inc.
    Inventors: Alexander P. LAZAREV, Pavel LAZAREV
  • Publication number: 20240000412
    Abstract: In some embodiments an X-ray system comprises a work-station and a mammography apparatus. The mammography apparatus can comprise: a breast positioning area; a diffraction enhanced X-ray imaging apparatus; and a diffractometer for analyzing structure of tissue within a breast. The diffraction enhanced X-ray imaging apparatus and the diffractometer can be configured to move in order to interchangeably align with the breast positioning area. The work-station can be configured to control, and to process data received from, the mammography apparatus.
    Type: Application
    Filed: July 13, 2023
    Publication date: January 4, 2024
    Applicant: EosDx Inc.
    Inventors: Alexander P. LAZAREV, Pavel LAZAREV
  • Patent number: 11751828
    Abstract: An in vivo human-tissue analysis and communication system produces a quantitative diagnostic indicator for human-tissue analyzed by the system. The system includes a human-tissue-analyzer subsystem with at least one human-tissue analyzer constructed to analyze human tissue and to produce a quantitative-diagnostic indicator. There is also a two-way communication subsystem constructed to allow the human-tissue-analyzer subsystem to send and receive information relevant to the quantitative-diagnostic indicator. The human-tissue-analyzer subsystem includes at least one tissue diffractometer operatively coupled to a computer database over a network, and configured for acquisition of human-tissue data and transfer to the computer database over the network.
    Type: Grant
    Filed: September 26, 2021
    Date of Patent: September 12, 2023
    Assignee: EosDx Inc.
    Inventors: Alexander Lazarev, Pavel Lazarev, Delvin Tai Wai Yuk
  • Publication number: 20230270396
    Abstract: The present disclosure relates to determining an efficacy of a therapeutic agent. A method for determining an efficacy of a therapeutic agent for a target disease can include measuring a molecular structure of a biological tissue of an animal at a first time and at a second time using a non-invasive biological tissue characterization technique. The method can further include observing a change of the molecular structure of the biological tissue between the first time and the second time, and determining the efficacy of the therapeutic agent based on the observed change in the molecular structure of the biological tissue. Before the first time, or between the first time and the second time, the animal received the therapeutic agent.
    Type: Application
    Filed: April 10, 2023
    Publication date: August 31, 2023
    Applicant: Arion Diagnostics, Inc.
    Inventors: Alexander P. LAZAREV, Delvin Tai Wai YUK, Pavel LAZAREV
  • Publication number: 20230240635
    Abstract: The present disclosure relates to determining a therapy efficacy. A method for determining an efficacy of a therapy for a disease in an animal patient can include measuring a molecular structure of a biological tissue of an animal patient at a first time and at a second time using a non-invasive biological tissue characterization technique. The method can further include observing a change of the molecular structure of the biological tissue between the first time and the second time, and determining the efficacy of the therapy based on the observed change in the molecular structure of the biological tissue. Before the first time, or between the first time and the second time, the animal patient received the therapy.
    Type: Application
    Filed: April 10, 2023
    Publication date: August 3, 2023
    Applicant: Arion Diagnostics, Inc.
    Inventors: Alexander P. LAZAREV, Delvin Tai Wai YUK, Pavel LAZAREV
  • Publication number: 20230240636
    Abstract: The present disclosure relates to determining a biological tissue structural marker for diagnosis of a disease using a biological tissue characterization technique. A method for determining a structural marker for a diagnosis of a disease can include measuring a first molecular structure of a biological tissue of a first population of animals, after a carcinogenic or pathogenic substance was introduced into the first population. A second molecular structure of the biological tissue of a second population of animals can be measured, wherein the second population did not receive the carcinogenic or pathogenic substance. A first and a second structural marker of the molecular structures of the biological tissue of the first and second populations, respectively, can be identified and compared to determine that the first structural marker is indicative that the biological tissue of the first population of animals was affected by the disease.
    Type: Application
    Filed: April 10, 2023
    Publication date: August 3, 2023
    Applicant: Arion Diagnostics, Inc.
    Inventors: Alexander P. LAZAREV, Delvin Tai Wai YUK, Pavel LAZAREV
  • Publication number: 20230207074
    Abstract: Provided herein are diffractometer-based global diagnostic systems and uses thereof. The systems may comprise one or more diffraction apparatus operatively coupled to a computer database over a network. The one or more diffraction apparatus may be configured for transfer of data such as pathology lab image data, diffraction pattern data, subject data, or any combination thereof to the computer database over the network. The systems may further comprise one or more computer processors operatively coupled to the one or more diffraction apparatus, which computer processors may be configured to receive the data from the diffraction apparatus, transmit the data to the computer database, and process the data using a data analytics algorithm which may provide a computer-aided diagnostic indicator for the individual subject.
    Type: Application
    Filed: June 14, 2021
    Publication date: June 29, 2023
    Applicant: Bragg Analytics, Inc.
    Inventors: Pavel LAZAREV, Alexander LAZAREV
  • Patent number: 11607188
    Abstract: Provided herein are diffractometer-based global in situ diagnostic systems and uses thereof. The systems may comprise one or more tissue diffractometers that are configured for acquiring in situ diffraction data for a subject, e.g., a patient, and that are operatively coupled to a computer database over a network. The one or more tissue diffractometers may be configured for transfer of data such as image data, diffraction pattern data, subject data, or any combination thereof to the computer database over the network. The systems may further comprise one or more computer processors operatively coupled to the tissue diffractometers, which computer processors may be configured to receive the data from the tissue diffractometers, transmit the data to the computer database, and process the data using a data analytics algorithm which may provide a computer-aided diagnostic indicator for the individual subject.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: March 21, 2023
    Assignee: EosDx Inc.
    Inventors: Pavel Lazarev, Alexander Lazarev
  • Publication number: 20220415505
    Abstract: Provided herein are diffractometer-based global in situ diagnostic systems and uses thereof. The systems may comprise one or more tissue diffractometers that are configured for acquiring in situ diffraction data for a subject, e.g., a patient, and that are operatively coupled to a computer database over a network. The one or more tissue diffractometers may be configured for transfer of data such as image data, diffraction pattern data, subject data, or any combination thereof to the computer database over the network. The systems may further comprise one or more computer processors operatively coupled to the tissue diffractometers, which computer processors may be configured to receive the data from the tissue diffractometers, transmit the data to the computer database, and process the data using a data analytics algorithm which may provide a computer-aided diagnostic indicator for the individual subject.
    Type: Application
    Filed: June 14, 2021
    Publication date: December 29, 2022
    Applicant: NISTA Diagnostics Inc.
    Inventors: Pavel LAZAREV, Alexander LAZAREV
  • Publication number: 20220013233
    Abstract: An in vitro human-tissue analysis and communication system produces a quantitative diagnostic indicator for in vitro human-tissue analyzed by the system. The system includes a human-tissue-analyzer subsystem with at least one human-tissue analyzer that analyzes in vitro samples of human tissue and produces a quantitative-diagnostic indicator of each sample. The system also includes a two-way communication subsystem that allows the human-tissue-analyzer subsystem to send and receive information relevant to the quantitative-diagnostic indicators. The human-tissue-analyzer subsystem includes at least one tissue diffractometer operatively coupled to a computer database over a network, and configured for acquisition of the in vitro samples, and transfer of the corresponding human-tissue data to the computer database over the network.
    Type: Application
    Filed: September 26, 2021
    Publication date: January 13, 2022
    Applicant: Bragg Analytics, Inc.
    Inventors: Alexander LAZAREV, Pavel LAZAREV, Delvin Tai Wai YUK
  • Publication number: 20220008027
    Abstract: An in vivo human-tissue analysis and communication system produces a quantitative diagnostic indicator for human-tissue analyzed by the system. The system includes a human-tissue-analyzer subsystem with at least one human-tissue analyzer constructed to analyze human tissue and to produce a quantitative-diagnostic indicator. There is also a two-way communication subsystem constructed to allow the human-tissue-analyzer subsystem to send and receive information relevant to the quantitative-diagnostic indicator. The human-tissue-analyzer subsystem includes at least one tissue diffractometer operatively coupled to a computer database over a network, and configured for acquisition of human-tissue data and transfer to the computer database over the network.
    Type: Application
    Filed: September 26, 2021
    Publication date: January 13, 2022
    Applicant: NISTA Diagnostics Inc.
    Inventors: Alexander LAZAREV, Pavel LAZAREV, Delvin Tai Wai YUK
  • Publication number: 20220013227
    Abstract: An animal-tissue analysis and communication system produces a quantitative-diagnostic indicator for animal-tissue analyzed by the system. The system includes an animal-tissue-analyzer subsystem with at least one animal-tissue analyzer constructed to analyze animal tissue and to produce an quantitative-diagnostic indicator. The system also includes a two-way communication subsystem constructed to allow the animal-tissue-analyzer subsystem to send and receive information relevant to the quantitative-diagnostic indicator. The animal-tissue-analyzer subsystem includes at least one tissue diffractometer operatively coupled to a computer database over a network, and is configured for acquisition and transfer of animal-tissue data, and transfer to the computer database over the network.
    Type: Application
    Filed: September 26, 2021
    Publication date: January 13, 2022
    Applicant: Arion Diagnostics, Inc.
    Inventors: Alexander LAZAREV, Pavel LAZAREV, Delvin Tai Wai YUK
  • Publication number: 20200255453
    Abstract: The present disclosure provides an energy storage molecular material, crystal dielectric layer and capacitor which may solve a problem of the further increase of volumetric and mass density of reserved energy associated with some energy storage devices, and at the same time reduce cost of materials.
    Type: Application
    Filed: February 14, 2020
    Publication date: August 13, 2020
    Inventor: Pavel Lazarev
  • Patent number: 10597407
    Abstract: The present disclosure provides an energy storage molecular material, crystal dielectric layer and capacitor which may solve a problem of the further increase of volumetric and mass density of reserved energy associated with some energy storage devices, and at the same time reduce cost of materials.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: March 24, 2020
    Assignee: CAPACITOR SCIENCES INCORPORATED
    Inventor: Pavel Lazarev
  • Publication number: 20180222924
    Abstract: The present disclosure provides an energy storage molecular material, crystal dielectric layer and capacitor which may solve a problem of the further increase of volumetric and mass density of reserved energy associated with some energy storage devices, and at the same time reduce cost of materials.
    Type: Application
    Filed: April 3, 2018
    Publication date: August 9, 2018
    Inventor: Pavel Lazarev
  • Patent number: 9515207
    Abstract: The present invention relates generally to the field of photovoltaic devices and particularly to the organic photovoltaic layer. More specifically, the organic photovoltaic layer comprises at least one organic compound of the general structural formula where Het1 and Het2 are predominantly planar polycyclic molecular systems; A is a bridging group providing a lateral bond of the molecular systems; and X is a counterion from a list comprising H+, Li+, Na+, K+, NH4+, Ba++, Zn++, Sr++, Ca++, Mg++, and any combination thereof. The photovoltaic layer is formed of column-like or planar supramolecules, it has absorption of electromagnetic radiation in at least one predetermined spectral subrange within a wavelength range from 400 to 3000 nm, and the molecular system Het1, the bridging group A, and the molecular system Het2 form a donor-bridge-acceptor system providing dissociation of excited electron-hole pairs.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: December 6, 2016
    Assignee: Cryscade Solar Limited
    Inventor: Pavel Lazarev
  • Publication number: 20160196929
    Abstract: An electrochemical energy storage device includes a first polymer electrode and a second polymer electrode spaced apart from the first polymer electrode such that a space is reserved between the first and second polymer electrodes. The space reserved between the first and second polymer electrodes contains an electrolyte that comprises a quinone compound. The first and second polymer electrodes each consist essentially of acid-dopable polymers.
    Type: Application
    Filed: August 15, 2014
    Publication date: July 7, 2016
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: David VONLANTHEN, Fred WUDL, Alan J. HEEGER, Pavel LAZAREV
  • Publication number: 20140058080
    Abstract: The present invention relates generally to the field of photovoltaic devices and particularly to the organic photovoltaic layer. More specifically, the organic photovoltaic layer comprises at least one organic compound of the general structural formula where Het1 and Het2 are predominantly planar polycyclic molecular systems; A is a bridging group providing a lateral bond of the molecular systems; and X is a counterion from a list comprising H+, Li+, Na+, K+, NH4+, Ba++, Zn++, Sr++, Ca++, Mg++, and any combination thereof. The photovoltaic layer is formed of column-like or planar supramolecules, it has absorption of electromagnetic radiation in at least one predetermined spectral subrange within a wavelength range from 400 to 3000 nm, and the molecular system Het1, the bridging group A, and the molecular system Het2 form a donor-bridge-acceptor system providing dissociation of excited electron-hole pairs.
    Type: Application
    Filed: September 3, 2013
    Publication date: February 27, 2014
    Inventor: Pavel Lazarev
  • Publication number: 20070195416
    Abstract: An interferential optical filter is provided comprising multiple layers each having real and/or imaginary refraction indexes. The values of the real and imaginary indexes depend on the strength of an external electric field. The material refraction indexes and the thickness of each layer and their combination are selected such as to provide an interference extremum in at least one region of the spectrum, for at least one polarization of incident light. At least one layer is made of an electro-optical material, which is anisotropic and made from at least one aromatic organic material. The molecules or fragments of molecules of the aromatic organic material have a flat structure. At least part of the layer of the electro-optical material has a crystalline structure with an intermolecular spacing of 3.4±0.3 ? along one of optical axes.
    Type: Application
    Filed: August 7, 2003
    Publication date: August 23, 2007
    Applicant: Nitto Denko Corporation
    Inventors: Pavel Lazarev, Serguei Palto, Michael Paukshto
  • Publication number: 20070166533
    Abstract: Two-phase film materials and methods for their fabrication are provided. The two-phase film materials typically comprise a first phase, comprising a crystalline film of supramolecules and a second phase, comprising a polymer film. The method of fabricating two-phase film materials comprise the steps of preparing a lyotropic liquid crystal of supramolecules comprising molecules of organic compound comprising at least one polar group; depositing a layer of the lyotropic liquid crystal; applying an external orienting action to the LLC layer; and treating the LCC layer with a binding agent.
    Type: Application
    Filed: March 27, 2007
    Publication date: July 19, 2007
    Applicant: NITTO DENKO CORPORATION
    Inventors: Pavel Lazarev, Elena Sidorenko